Piyanuch Kongtim - Concepedia

Author

Piyanuch Kongtim

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

P Kongtim, P. Kongtim, Piyanuch Kongtim

139

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Thammasat University University of California, Irvine Sorbonne Université Nationwide Children's Hospital

About

Piyanuch Kongtim is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, transplantation, and marrow transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	250
2	Blood Transplantation	5	5	197
3	Health Sciences	1	1	65
4	Public Health	1	1	24
5	Cell Biology	1	1	13

Piyanuch Kongtim

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors Antonio Di Stasi, Denái R. Milton, Li Mei Poon, Biology of Blood and Marrow Transplantation	2014	215
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation Stefan O. Ciurea, Peter F. Thall, Denái R. Milton, Biology of Blood and Marrow Transplantation	2015	209
Decrease post-transplant relapse using donor-derived expanded NK-cells Stefan O. Ciurea, Piyanuch Kongtim, Doris Soebbing, Leukemia	2021	96
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Stefan O. Ciurea, Mithun Vinod Shah, Rima M. Saliba, Biology of Blood and Marrow Transplantation	2017	94
Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation Sameh Gaballa, Isabell Ge, Riad El Fakih, Cancer	2016	85
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT Bhagirathbhai Dholaria, Bipin N. Savani, Myriam Labopin, Haematologica Cell TherapyTransplantationMarrow TransplantationConsensus RecommendationsStem Cell Transplantation	2019	84
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia Piyanuch Kongtim, Uday Popat, Antonio Jiménez, Biology of Blood and Marrow Transplantation	2015	74
Treatment of allosensitized patients receiving allogeneic transplantation Stefan O. Ciurea, Monzr M. Al Malki, Piyanuch Kongtim, Blood Advances ImmunohematologyTransplantation MedicineImmunologyDonor-specific Anti-hla AntibodiesC1q Positivity	2021	65
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation? Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Blood	2019	59
Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation Betül Oran, Piyanuch Kongtim, Uday Popat, Biology of Blood and Marrow Transplantation	2014	48

Page 1